|
|
 Previous Article | Table of Contents | Next Article 
Fibrin Regulation of Interleukin-8 Gene Expression in Human Vascular Endothelial Cells
Jiafan Qi,
Sandra Goralnick, and
Donald L. Kreutzer
From the Departments of Pathology and Surgery, Vision Immunology Center, University of Connecticut Health Center, Farmington, CT.
Recent studies in our laboratory, as well as others, have suggested that fibrin can regulate cell function in vitro and likely control inflammation in vivo by acting as a potent cell activator. This has led us to hypothesize that during tissue and vascular injury, fibrin can enhance leukocyte recruitment by inducing vascular endothelial cell expression of leukocyte chemotactic factors. To begin to test this hypothesis, we developed an in vitro model of in situ fibrin polymerization on human umbilical vein endothelial cell culture (HUVEC) and determined the ability of fibrin to induce HUVEC expression of the potent leukocyte chemotactic factor interleukin-8 (IL-8). Our initial studies showed that fibrin induced IL-8 expression in a time- and dose-dependent fashion. Fibrin-induced IL-8 expression in HUVEC could be seen as early as 2 hours post-fibrin stimulation. Additionally, fibrin concentrations as low as 30 µg/mL stimulated a detectable level of IL-8 antigen expression from HUVEC. We also showed that this fibrin induced IL-8 had the identical molecular weight and similar antigenic identity as recombinant and monocyte derived IL-8. Northern blot analysis showed that the IL-8 antigen increase seen in fibrin treated HUVEC was due to fibrin induced elevation of steady state mRNA expression in HUVEC. These data clearly support our hypothesis that fibrin is a potent vascular endothelial cell (VEC) activator that can directly contribute to leukocyte recruitment and activation by inducing leukocyte chemotactic factor expression from VEC.
Blood, Vol. 90 No. 9 (November 1), 1997:
pp. 3595-3602
© 1997 by The American Society of Hematology.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
A. R. Anand, M. Cucchiarini, E. F. Terwilliger, and R. K. Ganju
The Tyrosine Kinase Pyk2 Mediates Lipopolysaccharide-Induced IL-8 Expression in Human Endothelial Cells
J. Immunol.,
April 15, 2008;
180(8):
5636 - 5644.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Sevastos, S. E. Kennedy, D. R. Davis, M. Sam, P. W. Peake, J. A. Charlesworth, N. Mackman, and J. H. Erlich
Tissue factor deficiency and PAR-1 deficiency are protective against renal ischemia reperfusion injury
Blood,
January 15, 2007;
109(2):
577 - 583.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. C. Aird
The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome
Blood,
May 15, 2003;
101(10):
3765 - 3777.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. G. Welt, C. Tso, E. R. Edelman, M. A Kjelsberg, J. F Paolini, P. Seifert, and C. Rogers
Leukocyte recruitment and expression of chemokines following different forms of vascular injury
Vascular Medicine,
February 1, 2003;
8(1):
1 - 7.
[Abstract]
[PDF]
|
|
|
|
|
|
|
T.-H. Lee, H. Avraham, S.-H. Lee, and S. Avraham
Vascular Endothelial Growth Factor Modulates Neutrophil Transendothelial Migration via Up-regulation of Interleukin-8 in Human Brain Microvascular Endothelial Cells
J. Biol. Chem.,
March 15, 2002;
277(12):
10445 - 10451.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. T. Smiley, J. A. King, and W. W. Hancock
Fibrinogen Stimulates Macrophage Chemokine Secretion Through Toll-Like Receptor 4
J. Immunol.,
September 1, 2001;
167(5):
2887 - 2894.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. de Jonge, P. E. P. Dekkers, A. A. Creasey, C. E. Hack, S. K. Paulson, A. Karim, J. Kesecioglu, M. Levi, S. J. H. van Deventer, and T. van der Poll
Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia
Blood,
February 15, 2000;
95(4):
1124 - 1129.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
